KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Inventory (2016 - 2025)

Edwards Lifesciences (EW) has 16 years of Inventory data on record, last reported at $1.1 billion in Q4 2024.

  • For Q4 2024, Inventory rose 20.28% year-over-year to $1.1 billion; the TTM value through Dec 2024 reached $1.1 billion, up 20.28%, while the annual FY2024 figure was $1.1 billion, 20.28% up from the prior year.
  • Inventory reached $1.1 billion in Q4 2024 per EW's latest filing, down from $1.1 billion in the prior quarter.
  • Across five years, Inventory topped out at $1.2 billion in Q1 2024 and bottomed at $662.2 million in Q1 2020.
  • Average Inventory over 5 years is $857.8 million, with a median of $773.3 million recorded in 2020.
  • Peak YoY movement for Inventory: decreased 9.42% in 2021, then surged 36.24% in 2023.
  • A 5-year view of Inventory shows it stood at $802.3 million in 2020, then dropped by 9.42% to $726.7 million in 2021, then increased by 20.48% to $875.5 million in 2022, then grew by 3.2% to $903.5 million in 2023, then grew by 20.28% to $1.1 billion in 2024.
  • Per Business Quant database, its latest 3 readings for Inventory were $1.1 billion in Q4 2024, $1.1 billion in Q3 2024, and $1.2 billion in Q1 2024.